{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T02:24:45Z","timestamp":1787279085337,"version":"build-2736575974"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01917-3","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:56:09Z","timestamp":1787273769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AKT (Ser473) suppression mediates ceritinib cardiotoxicity through autophagic flux impairment and mitochondrial injury"],"prefix":"10.1038","author":[{"given":"Feng","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang-xi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-zheng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-qi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-qin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-zheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-hua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"1917_CR1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","volume":"17","author":"J Herrmann","year":"2020","unstructured":"Herrmann J. Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia. Nat Rev Cardiol. 2020;17:474\u2013502.","journal-title":"Nat Rev Cardiol"},{"key":"1917_CR2","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43:4229\u2013361.","journal-title":"Eur Heart J"},{"key":"1917_CR3","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1056\/NEJMra1100265","volume":"375","author":"JJ Moslehi","year":"2016","unstructured":"Moslehi JJ. Cardiovascular toxic effects of targeted cancer therapies. N Engl J Med. 2016;375:1457\u201367.","journal-title":"N Engl J Med"},{"key":"1917_CR4","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","volume":"371","author":"BJ Solomon","year":"2014","unstructured":"Solomon BJ, Mok T, Kim DW, Wu YL, Nakagawa K, Mekhail T, et al. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med. 2014;371:2167\u201377.","journal-title":"N Engl J Med"},{"key":"1917_CR5","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/S1470-2045(17)30339-X","volume":"18","author":"AT Shaw","year":"2017","unstructured":"Shaw AT, Kim TM, Crin\u00f2 L, Gridelli C, Kiura K, Liu G, et al. Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial. Lancet Oncol. 2017;18:874\u201386.","journal-title":"Lancet Oncol"},{"key":"1917_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.858279","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Chen C, Rong C, He X, Chen L. Anaplastic lymphoma kinase tyrosine kinase inhibitor-associated cardiotoxicity: a recent five-year pharmacovigilance study. Front Pharmacol. 2022;13:858279.","journal-title":"Front Pharmacol"},{"key":"1917_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40264-013-0047-5","volume":"36","author":"RR Shah","year":"2013","unstructured":"Shah RR, Morganroth J, Shah DR. Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval). Drug Saf. 2013;36:295\u2013316.","journal-title":"Drug Saf"},{"key":"1917_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s40264-023-01300-9","volume":"46","author":"T Niimura","year":"2023","unstructured":"Niimura T, Miyata K, Hamano H, Nounin Y, Unten H, Yoshino M, et al. Cardiovascular toxicities associated with anaplastic lymphoma kinase inhibitors: a disproportionality analysis of the WHO Pharmacovigilance Database (VigiBase). Drug Saf. 2023;46:545\u201352.","journal-title":"Drug Saf"},{"key":"1917_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf2584","volume":"9","author":"A Sharma","year":"2017","unstructured":"Sharma A, Burridge PW, McKeithan WL, Serrano R, Shukla P, Sayed N, et al. High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells. Sci Transl Med. 2017;9:eaaf2584.","journal-title":"Sci Transl Med"},{"key":"1917_CR10","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1101\/gad.269894.115","volume":"29","author":"GW Dorn","year":"2015","unstructured":"Dorn GW, Vega RB, Kelly DP. Mitochondrial biogenesis and dynamics in the developing and diseased heart. Genes Dev. 2015;29:1981\u201391.","journal-title":"Genes Dev"},{"key":"1917_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","volume":"21","author":"FJ Bock","year":"2020","unstructured":"Bock FJ, Tait SWG. Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol. 2020;21:85\u2013100.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1917_CR12","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1172\/JCI120849","volume":"128","author":"B Zhou","year":"2018","unstructured":"Zhou B, Tian R. Mitochondrial dysfunction in the pathophysiology of heart failure. J Clin Invest. 2018;128:3716\u201326.","journal-title":"J Clin Invest"},{"key":"1917_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.cell.2009.08.005","volume":"138","author":"A Chacinska","year":"2009","unstructured":"Chacinska A, Koehler CM, Milenkovic D, Lithgow T, Pfanner N. Importing mitochondrial proteins: machineries and mechanisms. Cell. 2009;138:628\u201344.","journal-title":"Cell"},{"key":"1917_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1379\/CSC-144R.1","volume":"11","author":"CC Deocaris","year":"2006","unstructured":"Deocaris CC, Kaul SC, Wadhwa R. On the brotherhood of the mitochondrial chaperones mortalin and heat shock protein 60. Cell Stress Chaperones. 2006;11:116\u201328.","journal-title":"Cell Stress Chaperones"},{"key":"1917_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-physiol-021317-121427","volume":"80","author":"S Sciarretta","year":"2018","unstructured":"Sciarretta S, Maejima Y, Zablocki D, Sadoshima J. The role of autophagy in the heart. Annu Rev Physiol. 2018;80:1\u201326.","journal-title":"Annu Rev Physiol"},{"key":"1917_CR16","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nm1574","volume":"13","author":"A Nakai","year":"2007","unstructured":"Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med. 2007;13:619\u201324.","journal-title":"Nat Med"},{"key":"1917_CR17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4161\/auto.6.5.11947","volume":"6","author":"M Taneike","year":"2010","unstructured":"Taneike M, Yamaguchi O, Nakai A, Hikoso S, Takeda T, Mizote I, et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy. 2010;6:600\u20136.","journal-title":"Autophagy"},{"key":"1917_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI73943","volume":"125","author":"S Lavandero","year":"2015","unstructured":"Lavandero S, Chiong M, Rothermel BA, Hill JA. Autophagy in cardiovascular biology. J Clin Invest. 2015;125:55\u201364.","journal-title":"J Clin Invest"},{"key":"1917_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbrc.2019.12.051","volume":"523","author":"S Kobayashi","year":"2020","unstructured":"Kobayashi S, Zhao F, Kobayashi T, Hagiwara M, Kaminaris A, Li C, et al. Hyperglycemia-induced cardiomyocyte death is mediated by lysosomal membrane injury and aberrant expression of cathepsin D. Biochem Biophys Res Commun. 2020;523:239\u201345.","journal-title":"Biochem Biophys Res Commun"},{"key":"1917_CR20","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1093\/cvr\/cvaf203","volume":"121","author":"Y Maejima","year":"2025","unstructured":"Maejima Y, Titus AS, Zablocki D, Sadoshima J. Recent progress regarding the role of autophagy in cardiac disease. Cardiovasc Res. 2025;121:2299\u2013317.","journal-title":"Cardiovasc Res"},{"key":"1917_CR21","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","volume":"14","author":"M Mauthe","year":"2018","unstructured":"Mauthe M, Orhon I, Rocchi C, Zhou X, Luhr M, Hijlkema KJ, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14:1435\u201355.","journal-title":"Autophagy"},{"key":"1917_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","volume":"17","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1. Autophagy. 2021;17:1\u2013382.","journal-title":"Autophagy"},{"key":"1917_CR23","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1161\/CIRCULATIONAHA.115.017443","volume":"133","author":"DL Li","year":"2016","unstructured":"Li DL, Wang ZV, Ding G, Tan W, Luo X, Criollo A, et al. Doxorubicin blocks cardiomyocyte autophagic flux by inhibiting lysosome acidification. Circulation. 2016;133:1668\u201387.","journal-title":"Circulation"},{"key":"1917_CR24","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.cmet.2023.02.006","volume":"35","author":"M Ozcan","year":"2023","unstructured":"Ozcan M, Guo Z, Valenzuela Ripoll C, Diab A, Picataggi A, Rawnsley D, et al. Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity. Cell Metab. 2023;35:928\u201342.","journal-title":"Cell Metab"},{"key":"1917_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning BD, Toker A. AKT\/PKB signaling: navigating the network. Cell. 2017;169:381\u2013405.","journal-title":"Cell"},{"key":"1917_CR26","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex. Science. 2005;307:1098\u2013101.","journal-title":"Science"},{"key":"1917_CR27","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.cellsig.2011.05.004","volume":"23","author":"I Hers","year":"2011","unstructured":"Hers I, Vincent EE, Tavar\u00e9 JM. Akt signalling in health and disease. Cell Signal. 2011;23:1515\u201327.","journal-title":"Cell Signal"},{"key":"1917_CR28","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1161\/CIRCULATIONAHA.105.595231","volume":"113","author":"B DeBosch","year":"2006","unstructured":"DeBosch B, Treskov I, Lupu TS, Weinheimer C, Kovacs A, Courtois M, et al. Akt1 is required for physiological cardiac growth. Circulation. 2006;113:2097\u2013104.","journal-title":"Circulation"},{"key":"1917_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1210\/en.2015-1709","volume":"157","author":"S Ock","year":"2016","unstructured":"Ock S, Lee WS, Ahn J, Kim HM, Kang H, Kim HS, et al. Deletion of IGF-1 receptors in cardiomyocytes attenuates cardiac aging in male mice. Endocrinology. 2016;157:336\u201345.","journal-title":"Endocrinology"},{"key":"1917_CR30","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1126\/science.292.5522.1728","volume":"292","author":"H Cho","year":"2001","unstructured":"Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB, et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science. 2001;292:1728\u201331.","journal-title":"Science"},{"key":"1917_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13:132\u201341.","journal-title":"Nat Cell Biol"},{"key":"1917_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14338","volume":"8","author":"M Palmieri","year":"2017","unstructured":"Palmieri M, Pal R, Nelvagal HR, Lotfi P, Stinnett GR, Seymour ML, et al. mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases. Nat Commun. 2017;8:14338.","journal-title":"Nat Commun"},{"key":"1917_CR33","doi-asserted-by":"publisher","first-page":"5584","DOI":"10.1172\/JCI128287","volume":"129","author":"K Asrani","year":"2019","unstructured":"Asrani K, Murali S, Lam B, Na CH, Phatak P, Sood A, et al. mTORC1 feedback to AKT modulates lysosomal biogenesis through MiT\/TFE regulation. J Clin Invest. 2019;129:5584\u201399.","journal-title":"J Clin Invest"},{"key":"1917_CR34","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1128\/MCB.00930-12","volume":"32","author":"C Parr","year":"2012","unstructured":"Parr C, Carzaniga R, Gentleman SM, Van Leuven F, Walter J, Sastre M. Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-\u03b2 precursor protein. Mol Cell Biol. 2012;32:4410\u20138.","journal-title":"Mol Cell Biol"},{"key":"1917_CR35","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"G Rena","year":"2017","unstructured":"Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017;60:1577\u201385.","journal-title":"Diabetologia"},{"key":"1917_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","volume":"603","author":"T Ma","year":"2022","unstructured":"Ma T, Tian X, Zhang B, Li M, Wang Y, Yang C, et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature. 2022;603:159\u201365.","journal-title":"Nature"},{"key":"1917_CR37","doi-asserted-by":"publisher","unstructured":"Son S, Kim Y, Jang KJ, Kim DE. Metformin activates AMP-activated protein kinase-transcription factor EB signaling to restore lysosomal and mitochondrial homeostasis and suppress epithelial-to-mesenchymal transition in oxidative stress-injured retinal pigment epithelium. Am J Pathol. 2026; S0002-9440(26)00167-7. https:\/\/doi.org\/10.1016\/j.ajpath.2026.05.009.","DOI":"10.1016\/j.ajpath.2026.05.009"},{"key":"1917_CR38","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1161\/CIRCULATIONAHA.108.798561","volume":"119","author":"H Sasaki","year":"2009","unstructured":"Sasaki H, Asanuma H, Fujita M, Takahama H, Wakeno M, Ito S, et al. Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation. 2009;119:2568\u201377.","journal-title":"Circulation"},{"key":"1917_CR39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1161\/CIRCRESAHA.108.190918","volume":"104","author":"S Gundewar","year":"2009","unstructured":"Gundewar S, Calvert JW, Jha S, Toedt-Pingel I, Ji SY, Nunez D, et al. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ Res. 2009;104:403\u201311.","journal-title":"Circ Res"},{"key":"1917_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2025.101284","volume":"15","author":"Q Wu","year":"2025","unstructured":"Wu Q, Zhao Y, Huang F. Metformin alleviates renal tubular injury in diabetic kidney disease by activating mitophagy and inhibiting ferroptosis via HIF-1\u03b1\/MIOX axis. J Pharm Anal. 2025;15:101284.","journal-title":"J Pharm Anal"},{"key":"1917_CR41","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1080\/15548627.2023.2259216","volume":"20","author":"Z Xu","year":"2024","unstructured":"Xu Z, Pan Z, Jin Y, Gao Z, Jiang F, Fu H, et al. Inhibition of PRKAA\/AMPK (Ser485\/491) phosphorylation by crizotinib induces cardiotoxicity via perturbing autophagosome-lysosome fusion. Autophagy. 2024;20:416\u201336.","journal-title":"Autophagy"},{"key":"1917_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev-nutr-071812-161148","volume":"34","author":"DG Hardie","year":"2014","unstructured":"Hardie DG. AMP-activated protein kinase: maintaining energy homeostasis at the cellular and whole-body levels. Annu Rev Nutr. 2014;34:31\u201355.","journal-title":"Annu Rev Nutr"},{"key":"1917_CR43","doi-asserted-by":"publisher","first-page":"325","DOI":"10.7150\/ijbs.29009","volume":"15","author":"H Wu","year":"2019","unstructured":"Wu H, Ding J, Li S, Lin J, Jiang R, Lin C, et al. Metformin promotes the survival of random-pattern skin flaps by inducing autophagy via the AMPK-mTOR-TFEB signaling pathway. Int J Biol Sci. 2019;15:325\u201340.","journal-title":"Int J Biol Sci"},{"key":"1917_CR44","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22:659\u201361.","journal-title":"FASEB J"},{"key":"1917_CR45","unstructured":"Zykadia (ceritinib) prescribing information [monograph on the Internet]. East Hanover (NJ): Novartis Pharmaceuticals Corporation; 2019 [cited 2026 Jun 20]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/211225s000lbl.pdf."},{"key":"1917_CR46","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4161\/auto.4451","volume":"3","author":"S Kimura","year":"2007","unstructured":"Kimura S, Noda T, Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy. 2007;3:452\u201360.","journal-title":"Autophagy"},{"key":"1917_CR47","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15:387\u2013407.","journal-title":"Nat Rev Cardiol"},{"key":"1917_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1172\/JCI62839","volume":"123","author":"JH van Berlo","year":"2013","unstructured":"van Berlo JH, Maillet M, Molkentin JD. Signaling effectors underlying pathologic growth and remodeling of the heart. J Clin Invest. 2013;123:37\u201345.","journal-title":"J Clin Invest"},{"key":"1917_CR49","doi-asserted-by":"publisher","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","volume":"28","author":"S Pickles","year":"2018","unstructured":"Pickles S, Vigi\u00e9 P, Youle RJ. Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr Biol. 2018;28:R170\u2013R185.","journal-title":"Curr Biol"},{"key":"1917_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s11658-016-0031-z","volume":"21","author":"WJ Liu","year":"2016","unstructured":"Liu WJ, Ye L, Huang WF, Guo LJ, Xu ZG, Wu HL, et al. p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation. Cell Mol Biol Lett. 2016;21:29.","journal-title":"Cell Mol Biol Lett"},{"key":"1917_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-cellbio-092910-154005","volume":"27","author":"N Mizushima","year":"2011","unstructured":"Mizushima N, Yoshimori T, Ohsumi Y. The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol. 2011;27:107\u201332.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1917_CR52","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1172\/JCI25900","volume":"115","author":"BT O\u2019Neill","year":"2005","unstructured":"O\u2019Neill BT, Abel ED. Akt1 in the cardiovascular system: friend or foe? J Clin Invest. 2005;115:2059\u201364.","journal-title":"J Clin Invest."},{"key":"1917_CR53","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-111315-125407","volume":"32","author":"N Raben","year":"2016","unstructured":"Raben N, Puertollano R. TFEB and TFE3: linking lysosomes to cellular adaptation to stress. Annu Rev Cell Dev Biol. 2016;32:255\u201378.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1917_CR54","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486\u2013541.","journal-title":"Cell Death Differ"},{"key":"1917_CR55","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1126\/science.1219855","volume":"337","author":"RJ Youle","year":"2012","unstructured":"Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science. 2012;337:1062\u20135.","journal-title":"Science"},{"key":"1917_CR56","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.drudis.2008.05.011","volume":"13","author":"T Force","year":"2008","unstructured":"Force T, Kerkel\u00e4 R. Cardiotoxicity of the new cancer therapeutics\u2013mechanisms of, and approaches to, the problem. Drug Discov Today. 2008;13:778\u201384.","journal-title":"Drug Discov Today"},{"key":"1917_CR57","doi-asserted-by":"publisher","unstructured":"Tie H, Hou M, Li Y, Pan M, Neumann D, Liu R, et al. Vacuolar H+-ATPase preserves cardiolipin homeostasis through the lysosomal-mitochondrial axis to restrain cardiac aging. Circulation. 2026. https:\/\/doi.org\/10.1161\/circulationaha.125.078376.","DOI":"10.1161\/circulationaha.125.078376"},{"key":"1917_CR58","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.3390\/ijms23031709","volume":"23","author":"HY Pan","year":"2022","unstructured":"Pan HY, Valapala M. Regulation of autophagy by the glycogen synthase kinase-3 (GSK-3) signaling pathway. Int J Mol Sci. 2022;23:1709.","journal-title":"Int J Mol Sci"},{"key":"1917_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109744","volume":"75","author":"B Hou","year":"2020","unstructured":"Hou B, Li Y, Li X, Zhang C, Zhao Z, Chen Q, et al. HGF protected against diabetic nephropathy via the autophagy-lysosome pathway in podocytes by modulating PI3K\/Akt-GSK3\u03b2-TFEB axis. Cell Signal. 2020;75:109744.","journal-title":"Cell Signal"},{"key":"1917_CR60","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4368","volume":"358","author":"S Klaeger","year":"2017","unstructured":"Klaeger S, Heinzlmeir S, Wilhelm M, Polzer H, Vick B, Koenig PA, et al. The target landscape of clinical kinase drugs. Science. 2017;358:eaan4368.","journal-title":"Science"},{"key":"1917_CR61","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/nbt.1990","volume":"29","author":"MI Davis","year":"2011","unstructured":"Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, et al. Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol. 2011;29:1046\u201351.","journal-title":"Nat Biotechnol"},{"key":"1917_CR62","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJMoa1311107","volume":"370","author":"AT Shaw","year":"2014","unstructured":"Shaw AT, Kim DW, Mehra R, Tan DS, Felip E, Chow LQ, et al. Ceritinib in ALK-rearranged non-small-cell lung cancer. N Engl J Med. 2014;370:1189\u201397.","journal-title":"N Engl J Med"},{"key":"1917_CR63","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj5559","volume":"380","author":"N Malik","year":"2023","unstructured":"Malik N, Ferreira BI, Hollstein PE, Curtis SD, Trefts E, Weiser Novak S, et al. Induction of lysosomal and mitochondrial biogenesis by AMPK phosphorylation of FNIP1. Science. 2023;380:eabj5559.","journal-title":"Science"},{"key":"1917_CR64","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","volume":"19","author":"M Foretz","year":"2023","unstructured":"Foretz M, Guigas B, Viollet B. Metformin: update on mechanisms of action and repurposing potential. Nat Rev Endocrinol. 2023;19:460\u201376.","journal-title":"Nat Rev Endocrinol"},{"key":"1917_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02302-0","volume":"24","author":"B Wang","year":"2025","unstructured":"Wang B, Wang Z, Zhou Z, Liu G, Jiang Z, Zheng M, et al. Inhibition of 6-phosphogluconate dehydrogenase suppresses esophageal squamous cell carcinoma growth and enhances the anti-tumor effects of metformin via the AMPK\/mTOR pathway. Mol Cancer. 2025;24:97.","journal-title":"Mol Cancer"},{"key":"1917_CR66","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jpha.2023.08.012","volume":"14","author":"T Yang","year":"2024","unstructured":"Yang T, Yuan J, Peng Y, Pang J, Qiu Z, Chen S, et al. Metformin: a promising clinical therapeutical approach for BPH treatment via inhibiting dysregulated steroid hormones-induced prostatic epithelial cells proliferation. J Pharm Anal. 2024;14:52\u201368.","journal-title":"J Pharm Anal"},{"key":"1917_CR67","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1038\/s12276-024-01357-1","volume":"56","author":"M Ko","year":"2024","unstructured":"Ko M, Kim J, Lazim R, Lee JY, Kim JY, Gosu V, et al. The anticancer effect of metformin targets VDAC1 via ER-mitochondria interactions-mediated autophagy in HCC. Exp Mol Med. 2024;56:2714\u201325.","journal-title":"Exp Mol Med"},{"key":"1917_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115361","volume":"211","author":"J Tetterton-Kellner","year":"2024","unstructured":"Tetterton-Kellner J, Jensen BC, Nguyen J. Navigating cancer therapy-induced cardiotoxicity: from pathophysiology to treatment innovations. Adv Drug Deliv Rev. 2024;211:115361.","journal-title":"Adv Drug Deliv Rev"},{"key":"1917_CR69","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/509282a","volume":"509","author":"JA Clayton","year":"2014","unstructured":"Clayton JA, Collins FS. Policy: NIH to balance sex in cell and animal studies. Nature. 2014;509:282\u20133.","journal-title":"Nature"},{"key":"1917_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2023.12.002","volume":"187","author":"E Sassu","year":"2024","unstructured":"Sassu E, Tumlinson G, Stefanovska D, Fern\u00e1ndez MC, Iaconianni P, Madl J, et al. Age-related structural and functional changes of the intracardiac nervous system. J Mol Cell Cardiol. 2024;187:1\u201314.","journal-title":"J Mol Cell Cardiol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01917-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01917-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01917-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T02:02:28Z","timestamp":1787277748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01917-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":70,"alternative-id":["1917"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01917-3","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author Bo Yang is a member of the Editorial Board of the journal Acta Pharmacologica Sinica, but she has not been involved in the peer-review or decision-making process for this manuscript. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}